SCHEMBL6847601

SCHEMBL6847601

CC(O)C(NC(=O)[C@@H](NC(=O)OCc1ccccc1Cl)C(C)C)[C@H](F)C(=O)OC(C)(C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.40
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
HPGD P15428 1/20 0.39
CYP2C19 P33261 1/20 0.39
TACR1 P25103 1/20 0.37
KEAP1 Q14145 1/20 0.37
NFE2L2 Q16236 1/20 0.37
CTSL P07711 1/20 0.37
CTSS P25774 1/20 0.37
CASP3 P42574 3/20 0.36
CTSD P07339 2/20 0.36
CASP1 P29466 1/20 0.36
CASP7 P55210 1/20 0.36
CASP9 P55211 1/20 0.36
CASP6 P55212 1/20 0.36
CASP8 Q14790 1/20 0.36
MEN1 O00255 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5174682 0.79 REN (0.39) ALDH1A1CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL5175236 0.74 ALDH1A1 (0.53) ALDH1A1CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL9439010 0.73 CYP1A2 (0.52) ALDH1A1CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL8145861 0.73 CYP1A2 (0.48) ALDH1A1CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL25908075 0.70 SYK (0.57) CTSLCTSSCASP3CTSD
SCHEMBL12467351 0.69 HPGD (0.50) ALDH1A1CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL15338739 0.69 CYP1A2 (0.49) ALDH1A1CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL9608962 0.69 SYK (0.58) CTSLCTSSCASP3CTSDCASP1
SCHEMBL12401101 0.68 CYP1A2 (0.48) ALDH1A1CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL15338663 0.68 CYP1A2 (0.48) ALDH1A1CYP1A2CYP3A4CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6716818-B2 DIPEPTIDE DERIVATIVES CYTOVIA, INC. 2004-04-06 US disclosed
US-20020058631-A1 Caspase inhibitors and the use thereof CYTOVIA, INC. 2002-05-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020058631-A1 Caspase inhibitors and the use thereof CASP1, CASP3, CASP10 ALDH1A1 2519/4885CYP1A2 3277/4885CYP3A4 2604/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.